Shearman-Led Medical Device Co. Inks $800M Drug Biz Sale
Medical device and product business Boston Scientific, working with Shearman & Sterling LLP, unveiled plans Tuesday to sell its BTG Specialty Pharmaceuticals unit to private equity-backed European specialty pharmaceutical group SERB...To view the full article, register now.
Already a subscriber? Click here to view full article